Author

CA Hanson

Observed names: C A Hanson, Curtis A. Hanson

Observed institutions: University of Copenhagen, University of Minnesota, Mayo Clinic, University of Michigan, University of Rochester Medicine, Michigan Medicine

OpenAlex ID: A5010972577

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

2009 · A Tefferi, K-H Lim, et al. · Leukemia · 268

Flow Cytometric Assessment of TCR-VβExpression in the Evaluation of Peripheral Blood Involvement by T-Cell Lymphoproliferative Disorders

2004 · William G. Morice, Teresa Kimlinger, et al. · American Journal of Clinical Pathology · 99

Flow Cytometric Assessment of TCR-V b Expression in the Evaluation of Peripheral Blood Involvement by T-Cell Lymphoproliferative Disorders: A Comparison With Conventional T-Cell Immunophenotyping and Molecular Genetic Techniques

2004 · William G. Morice, Teresa Kimlinger, et al. · American Journal of Clinical Pathology · 92

PDF

CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia [see comments]

1990 · CA Hanson, TE Gribbin, et al. · Blood · 62

PDF

Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique

1987 · CA Hanson, KJ Gajl-Peczalska, et al. · Blood · 46

PDF

Acute Myeloid Leukemia With Minimal Differentiation:A Multiple Parameter Study

1998 · Patti L. Cohen, James D. Hoyer, et al. · American Journal of Clinical Pathology · 42

Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: Comparison with flow cytometric immunophenotyping

1992 · Curtis A. Hanson, Charles W. Ross, et al. · Human Pathology · 38

S100-positive, T-cell chronic lymphoproliferative disease: an aggressive disorder of an uncommon T-cell subset

1991 · CA Hanson, PL Bockenstedt, et al. · Blood · 28

PDF

Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era

2024 · Paul J. Hampel, Kari G. Rabe, et al. · Leukemia · 16

Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23

1987 · PD Savage, CA Hanson, et al. · Blood · 13

PDF

Disease-Modifying Potential of BET Inhibitor Pelabresib (CPI-0610) As Demonstrated By Improvements in Bone Marrow Function and Clinical Activity in Patients with Myelofibrosis - Preliminary Data

2021 · Srdan Verstovsek, Mohamed E Salama, et al. · Blood · 9

T cell receptor β-chain gene rearrangement without γ-chain gene rearrangement in cutaneous T cell lymphoma: An unusual finding

1990 · Vincent C. Ho, Erik R. Hansen, et al. · Clinical Immunology and Immunopathology · 5

DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genes

1993 · Susan Miesfeldt, Suil Kim, et al. · Cancer Genetics and Cytogenetics · 1

PDF

Abstract 4228: Validation of the CLL treatment infection model (CLL-TIM) in patients with newly diagnosed chronic lymphocytic leukemia (CLL)

2026 · Raphael Mwangi, Tait D. Shanafelt, et al. · Cancer Research

Abstract 1191: Depth of immunoparesis predicts time to first therapy in newly diagnosed monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

2026 · Yuan Yao, Kari G. Rabe, et al. · Cancer Research

Treatment-relevant misdiagnosis of autoimmune myelofibrosis

2025 · Naseema Gangat, Kaaren K. Reichard, et al. · Haematologica

PDF

Frequency, Hematopathology and Detection of a New Isodicentric Variant of Deletion 20q.

2006 · Stephanie R. Fink, Stephanie A. Smoley, et al. · Blood

The changing field of hematopathology. Tradition versus technology.

1990 · C A Hanson · PubMed

Works count: 18

Citation count: 718

H-index: 10

I10-index: 10